Cargando…

Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy

OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Lerner, Minna, Medin, Joakim, Jamtheim Gustafsson, Christian, Alkner, Sara, Olsson, Lars E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784680/
https://www.ncbi.nlm.nih.gov/pubmed/35083159
http://dx.doi.org/10.3389/fonc.2021.812643
_version_ 1784638793036333056
author Lerner, Minna
Medin, Joakim
Jamtheim Gustafsson, Christian
Alkner, Sara
Olsson, Lars E.
author_facet Lerner, Minna
Medin, Joakim
Jamtheim Gustafsson, Christian
Alkner, Sara
Olsson, Lars E.
author_sort Lerner, Minna
collection PubMed
description OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there are no clinical implementations reported for brain tumors. Based on a preceding validation study of sCT, this study aims to investigate MRI-only brain RT through a prospective clinical feasibility study with endpoints for dosimetry and patient setup. MATERIAL AND METHODS: Twenty-one glioma patients were included. MRI Dixon images were used to generate sCT images using a CE-marked deep learning-based software. RT treatment plans were generated based on MRI delineated anatomical structures and sCT for absorbed dose calculations. CT scans were acquired but strictly used for sCT quality assurance (QA). Prospective QA was performed prior to MRI-only treatment approval, comparing sCT and CT image characteristics and calculated dose distributions. Additional retrospective analysis of patient positioning and dose distribution gamma evaluation was performed. RESULTS: Twenty out of 21 patients were treated using the MRI-only workflow. A single patient was excluded due to an MRI artifact caused by a hemostatic substance injected near the target during surgery preceding radiotherapy. All other patients fulfilled the acceptance criteria. Dose deviations in target were within ±1% for all patients in the prospective analysis. Retrospective analysis yielded gamma pass rates (2%, 2 mm) above 99%. Patient positioning using CBCT images was within ± 1 mm for registrations with sCT compared to CT. CONCLUSION: We report a successful clinical study of MRI-only brain radiotherapy, conducted using both prospective and retrospective analysis. Synthetic CT images generated using the CE-marked deep learning-based software were clinically robust based on endpoints for dosimetry and patient positioning.
format Online
Article
Text
id pubmed-8784680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87846802022-01-25 Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy Lerner, Minna Medin, Joakim Jamtheim Gustafsson, Christian Alkner, Sara Olsson, Lars E. Front Oncol Oncology OBJECTIVES: MRI-only radiotherapy (RT) provides a workflow to decrease the geometric uncertainty introduced by the image registration process between MRI and CT data and to streamline the RT planning. Despite the recent availability of validated synthetic CT (sCT) methods for the head region, there are no clinical implementations reported for brain tumors. Based on a preceding validation study of sCT, this study aims to investigate MRI-only brain RT through a prospective clinical feasibility study with endpoints for dosimetry and patient setup. MATERIAL AND METHODS: Twenty-one glioma patients were included. MRI Dixon images were used to generate sCT images using a CE-marked deep learning-based software. RT treatment plans were generated based on MRI delineated anatomical structures and sCT for absorbed dose calculations. CT scans were acquired but strictly used for sCT quality assurance (QA). Prospective QA was performed prior to MRI-only treatment approval, comparing sCT and CT image characteristics and calculated dose distributions. Additional retrospective analysis of patient positioning and dose distribution gamma evaluation was performed. RESULTS: Twenty out of 21 patients were treated using the MRI-only workflow. A single patient was excluded due to an MRI artifact caused by a hemostatic substance injected near the target during surgery preceding radiotherapy. All other patients fulfilled the acceptance criteria. Dose deviations in target were within ±1% for all patients in the prospective analysis. Retrospective analysis yielded gamma pass rates (2%, 2 mm) above 99%. Patient positioning using CBCT images was within ± 1 mm for registrations with sCT compared to CT. CONCLUSION: We report a successful clinical study of MRI-only brain radiotherapy, conducted using both prospective and retrospective analysis. Synthetic CT images generated using the CE-marked deep learning-based software were clinically robust based on endpoints for dosimetry and patient positioning. Frontiers Media S.A. 2022-01-10 /pmc/articles/PMC8784680/ /pubmed/35083159 http://dx.doi.org/10.3389/fonc.2021.812643 Text en Copyright © 2022 Lerner, Medin, Jamtheim Gustafsson, Alkner and Olsson https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lerner, Minna
Medin, Joakim
Jamtheim Gustafsson, Christian
Alkner, Sara
Olsson, Lars E.
Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title_full Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title_fullStr Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title_full_unstemmed Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title_short Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
title_sort prospective clinical feasibility study for mri-only brain radiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784680/
https://www.ncbi.nlm.nih.gov/pubmed/35083159
http://dx.doi.org/10.3389/fonc.2021.812643
work_keys_str_mv AT lernerminna prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy
AT medinjoakim prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy
AT jamtheimgustafssonchristian prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy
AT alknersara prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy
AT olssonlarse prospectiveclinicalfeasibilitystudyformrionlybrainradiotherapy